Abstracts submitted for consideration should reflect new or recent work. Abstracts are limited to 250 words and should not contain charts, figures, references, etc. Abstracts should adequately describe the content and focus of the proposed presentation and follow the general outline of background, methods, results, and conclusions. 

Below, you will find details about submitting abstracts. If you have any questions as you complete this process, please contact info@nhpvc.org for general conference questions or contact the program planner directly for abstract submission questions (Katy Head, headkj@iu.edu). 

Have the following information ready to submit through the online submission system: 

1. Author/collaborator names, degrees/title, affiliations, city/state, and email addresses (Please indicate the presenting author.) 
2. Paper/poster title of up to 20 words of text 
3. Abstract of up to 250 words of text 
4. Whether you wish for your abstract to be considered as: 
   • A poster presentation 
   • Short oral presentation (15 minutes) – This type of abstract would typically be about a single project or initiative. 
   • Long oral presentation (30 minutes) – This type of abstract would typically be about a more complex project or initiative and may include co-presenters. 
   • Please note: Program planners will try to honor, but cannot guarantee, preference requests.
5. Select which of the four Focus Tracks your abstract most aligns with

In fairness to the competitive submission process, submit your abstract for consideration only if you or one of your collaborators anticipate being able to register for and attend the conference to present your work (or arrange to have someone else present your work in the event that an emergency prevents your attendance). 

Abstracts will be submitted to blind peer review and will be evaluated on quality and relevance. Incomplete abstracts will not be reviewed or considered for inclusion in the program. 

1. Vaccination & Prevention: This track will focus on measures to prevent HPV infection, including education and awareness, advocacy, policy, vaccination, sexual health, health disparities, and more. Speakers will be encouraged to share programs, practices, and materials that have been successful in the realm of HPV prevention. Participants will leave with new ideas and actionable items. 
2. Research & Best Practices: This track invites area experts and researchers to present findings directly related to public-facing HPV care and prevention. Presentations should not be overly technical, but should privilege projects that include evaluation data, consensus statements, or similar approaches to establishing best practices. Applicable topics might include health equity, best practices, health communication, dissemination, or implementation science. 
3. Cancer Screening & Treatment: This track is focused on the screening and treatment of HPV-related cancers. Innovative and emerging methods, as well as those with high compliance and success, should be discussed. Topics might also include related policy and metrics. As with all tracks, presentations are aimed at those in public-facing environments to aid in understanding and communication. 
4. Public Health & Collaboration: This track seeks to help organizations collaborate and engage to further public health initiatives around HPV. Applicable topics might include health disparities and equity, legislation, policies, examples of successful partnerships, or public health outreach programs. 

• Call for abstracts submissions opens June 15, 2024. 
• Deadline for abstract submission is September 15, 2024 at 8pm Eastern Standard Time. 
• Deadline for reviewers to complete review of abstracts is October 15, 2024 at 8pm Eastern Standard Time. 
• Program decisions will go out on November 15, 2024. 
• Conference registration and hotel reservations will open in November.